A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.

Published in:

2013

By:

• Kottschade LA;
• Suman VJ;
• Perez DG;
• McWilliams RR;
• Kaur JS;
• Amatruda TT 3rd;
• Geoffroy FJ;
• Gross HM;
• Cohen PA;
• Jaslowski AJ;
• Kosel ML;
• Markovic SN;
• Kottschade, Lisa A;
• Suman, Vera J;
• Perez, Domingo G;
• McWilliams, Robert R;
• Kaur, Judith S;
• Amatruda, Thomas T 3rd;
• Geoffroy, Francois J;
• Gross, Howard M

Publication type:

journal article